Amanda Cashin

Overview

A prominent venture capital investor specializing in genomics-driven startups. She co-founded Illumina For Startups and Illumina Accelerator, initiatives focused on creating an innovation ecosystem for the genomics industry by partnering with leading venture capital investors and entrepreneurs to create, launch, and grow genomics startups. These initiatives include Illumina Accelerator, founded in 2014, and Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina, launched in Fall 2021. Previously, she served as Senior Vice President of Alexandria Venture Investments at Alexandria Real Estate Equities, Inc., where she led investments in breakthrough life science and technology companies. She earned a Ph.D. in Chemical Biology from the California Institute of Technology and graduated summa cum laude with a Bachelor's degree in Physical Organic Chemistry from the University of Colorado, Boulder. Her investment portfolio includes companies such as Pandora Biosciences, Terrapeutics Pharma, CRISP-HR Therapeutics, Dama Health, Parallel Health, Yali Biosciences, 4SR Biosciences, Viridian Seeds, NewStem, Nusantics, Genegoggle, Rubik Therapeutics, Oshun Medical, Cache, B4XTherapeutics, Mitra bio, Broken String Biosciences, MultiplAI Health, Flightpath Biosciences, EpiCombi.AI, NonExomics, Rethink Bio, Acrobat Genomics, Bixbio, ImYoo, Doloromics, Solena, and BiotaX. She is also a Board Member of the Caltech Alumni Association and serves as a Venture Advisor at Wilson Hill Ventures and an Expert-in-Residence at Digitalis Commons.